Profil
Jim Pepin currently works at Aimmune Therapeutics, Inc., as Senior Vice President & General Counsel and Legend Biotech Corp., as General Counsel from 2023.
Aktive Positionen von Jim Pepin
| Unternehmen | Position | Beginn |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | General Counsel | - |
| LEGEND BIOTECH CORPORATION | General Counsel | 01.11.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LEGEND BIOTECH CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
